IP Library Granted Patent US 8,464,707
Granted Patent B2
US 8,464,707 · App. 10/572,316 · Granted Jun 18, 2013

Compliance monitor and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,464,707
App. No.
10/572,316
Granted
Jun 18, 2013
Kind
B2
Abstract

A compliance monitor ( 20 ) is attachable to or forms part of a drug delivery device, such as an inhaler ( 2 ). The monitor comprises a flexible portion ( 38 ) to enable a switch which is actuated by a user when delivering a dose of medicament. The monitor further comprises a sensor for sensing whether the device is properly positioned in contact with or relative to the user's body for administration of the medicament. For example, where the device is an inhaler and the sensor a temperature sensor, temperature variations caused by insertion of an inhaler mouthpiece into the user's mouth indicate whether the dose has been delivered into the patient's mouth. A memory in the compliance monitor stores a compliance record indicating whether or not the device was properly positioned each time a dose was delivered.

Claims (23)

1. A compliance monitor for a drug delivery device with a mouthpiece for administering a drug, comprising:

a switch actuatable by a user on delivering a dose from a drug delivery device;

a sensor for detecting whether the device is properly positioned in contact with or relative to the user's body for delivery of the dose; and

a processor coupled to the switch and the sensor for recording whether or not the device was properly positioned when the switch was actuated;

wherein the compliance monitor is removably attachable to the mouthpiece of the drug delivery device;

wherein the sensor is a temperature sensor for sensing body temperature and the temperature sensor is mounted so that the temperature sensor enters or contacts the user's mouth when the mouthpiece is placed in the mouth, and wherein the compliance monitor comprises a housing and the sensor is mounted at the end of a protruding portion of the housing such that the sensor does not affect the normal operation of the drug delivery device.

2. The compliance monitor according to claim 1 , comprising a clock coupled to the processor and in which the time of actuation of the switch is recorded.

3. The compliance monitor according to claim 1 , wherein the drug delivery device is an inhaler operated by the user depressing a pressurized canister containing the drug, and wherein the switch is a pressure-operated switch actuatable as the user depresses the canister.

4. The compliance monitor according to claim 1 , in which a change in an output of a sensor characteristic of correct use of the drug delivery device is used to determine whether the device was properly positioned when the dose was delivered.

5. The compliance monitor according to claim 1 , further comprising an output for downloading data to a docking station or a computer.

6. The compliance monitor according to claim 1 , in which data recorded comprises a compliance record of use of the drug delivery device, including a record of whether the sensor output indicates that the device was properly positioned on each occasion that a dose has been delivered.

7. A docking station for use with the compliance monitor as defined in claim 1 , the docking station and the compliance monitor comprising respective contacts.

8. A combination compliance monitor for a drug delivery device and non-transitory computer-readable medium carrying a computer program for programming a general purpose computer to receive and process data downloaded from a compliance monitor, the combination comprising:

a compliance monitor according to claim 1 ; and

a non-transitory computer-readable medium carrying a computer program for programming a general purpose computer to receive and process data downloaded from the compliance monitor according to claim 1 .

9. A drug delivery device comprising a compliance monitor as defined in claim 1 .

10. A method of using a compliance monitor as defined in claim 1 , to monitor use of a drug delivery device for administration of a drug, comprising the steps of:

determining when a user operates the device to deliver a dose of the drug;

sensing whether the device is properly positioned in contact with or relative to the user's body when the dose is delivered; and

recording for each operation of the device whether or not the device was properly positioned.

11. The method according to claim 10 , further comprising the step of determining and recording the time of each operation of the device.

12. The method according to claim 10 , in which the drug delivery device is for oral administration of the drug and proper positioning of the device is proper positioning in the user's mouth.

13. The method according to claim 10 , further comprising the step of downloading recorded data from the compliance monitor to a docking station or a computer to allow a compliance record to be reviewed.

Assignments (20)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 27, 2025
From: COVIS PHARMA GBMH
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 071409/0368 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
RELEASE OF SECURITY INTEREST Recorded Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
RELEASE OF SECURITY INTEREST Recorded Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
SECURITY INTEREST Recorded Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
BUSINESS TRANSFER AND CONTRIBUTION AGREEMENT Recorded Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
RELEASE OF SECURITY INTEREST Recorded Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
SECURITY INTEREST Recorded Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
SECURITY INTEREST Recorded Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
CHANGE OF NAME Recorded Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
MERGER Recorded Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
MERGER Recorded Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
CHANGE OF NAME Recorded Mar 21, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030057/0633 →
CHANGE OF NAME Recorded Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2006
From: JONGEJAN, ROBERTO; FINK-WAGNER, ANTJE-HENRIETTE; FERRIS, CHRISTOPHER
To: ALTANA PHARMA AG
Reel/Frame 017635/0258 →